IDEXX CEO Mazelsky Sells $17.7 Million Of Stock After Exercising Options
Jonathan Mazelsky still holds 83,803 IDEXX shares after selling 25,140 on Wednesday, the same day he exercised options.
IDEXX Laboratories CEO Jonathan Jay Mazelsky sold 25,140 shares of the company's stock on Wednesday at an average $703.19, a sale valued at $17.7 million, according to a Form 4, the report insiders file after trading. The shares came from stock options he exercised the same day.
Options exercised, shares sold at once
Mazelsky exercised a non-qualified stock option, a right to buy shares, for 25,140 shares at $178.26 each. Per the filing, the grant became exercisable over five yearly tranches, the first on February 14, 2019.
He then sold the same number of shares in 13 open-market transactions on Wednesday. Prices ran from $698.26 on the first block of 1,945 shares to $711.95 on the last block of 331. The filing's footnotes put the underlying trading ranges between a low of $697.80 and a high of $712.34 per share.
The largest block was 4,540 shares at $701.36, followed by 4,075 shares at $699.33 and 3,950 shares at $703.45.
What Mazelsky still owns
Before the sale, Mazelsky's direct holding stood at 108,943.302 shares, including the 25,140 he had just acquired. After the last trade, 83,803.302 shares remained in that direct line, worth about $56.2 million at Thursday's close of $670.71.
The sale equals about 23.08% of his prior stake. The sale prices all sat above that Thursday close.
The company and the stock
IDEXX develops, makes and distributes diagnostic products and services, mainly for veterinary clinics, livestock, poultry and dairy producers, and water testing, according to its annual report for 2025. Its largest unit, the Companion Animal Group, sells in-clinic analyzers, rapid test kits, reference laboratory testing and practice software to veterinarians.
IDXX shares are down about 1% this year as of Thursday's close.
The filing shows no earlier IDXX sale by Mazelsky in the 90 days starting August 7.
At Thursday's close of $670.71, the remaining 83,803.302 shares were valued at about $56.2 million.
Sources
- Form 4 — Jonathan Jay Mazelsky (IDXX) — SEC EDGAR